Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 105

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 105
---
 receive (a) a cash amount per Common Share, which is currently estimated to be approximately $1.82 per
Common Share and will be finally determined based upon the Company’s cash balance immediately prior to the Effective Time after deducting certain transaction costs, the aggregate amount of outstanding liabilities, and a transaction fee to the
Purchaser, and (b) one CVR for each Common Share; (ii) the Compensation Resolution that will entitle the holder to receive, following Closing, contingent cash payments described in, and subject to and in accordance with the terms and
conditions of, the CVR Agreement; and (ii) in the event that the Arrangement Resolution is not approved or the Arrangement is otherwise terminated, (a) the Liquidation Resolution, and (b) the Liquidator Resolution.

Record Date and Voting Information

Only
Shareholders who hold Common Shares at the close of business on the Record Date will be entitled to receive notice of, and to vote at, the Special Meeting. Each Common Share outstanding on the Record Date will be entitled to one vote on each of the
Arrangement Resolution, the Compensation Resolution, the Liquidation Resolution and the Liquidator Resolution. Each Common Share outstanding on the Record Date will be entitled to one vote on the Arrangement Resolution. As of the Record Date, there
were 43,108,362 issued and outstanding Common Shares.

Broker non-votes and proxies marked
“ABSTAIN” will be counted only for the purpose of determining whether a quorum is present at the Special Meeting and not as votes cast. Such broker non-votes and proxies marked
“ABSTAIN” will have no effect on the outcome of the various matters to be voted upon at the Special Meeting. Abstentions will have no effect on the outcome of the vote to approve the Arrangement Resolution, the Liquidation Resolution and
the Liquidator Resolution.

Quorum

Under the by-laws of the Company, a quorum for the transaction of business at the Special Meeting is
two Persons who are, or who represent by proxy, Shareholders who, in the aggregate, hold Common Shares to which are attached at least 25% of the votes attached to all of the issued Common Shares Company entitled to voting rights at the Special
Meeting. Broker non-votes and proxies marked “ABSTAIN” will be counted for purposes of determining the presence or absence of a quorum for the transaction of business at the Special Meeting. In the
event that a quorum is not present